• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Did Medtech M&A Come up Short in 2023?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 15, 2024 at 10:12: AM
via A new report from EY shows that while M&A spend rose in pharma and Lifesciences there was a decline in the medical device industry. John Babbitt, Partner, Life Sciences, EY, spoke with MD+DI to discuss the findings of the EY M&A Firepower Report.

article source
 

<



Similar threads

cafead
Lots of drug companies talk about putting patients first — but this one actually did
Replies
0
Views
52
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
What did Big Pharma CEOs get paid in 2023?
Replies
0
Views
92
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
How did the pharmaceutical industry treat artificial intelligence in Q3 2023 filings?
Replies
0
Views
207
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Replies
0
Views
196
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biopharma Hires Expect More Than They Did Before the Pandemic
Replies
0
Views
148
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote